Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-04-19
2011-04-19
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S180000, C544S333000, C544S346000, C544S361000, C546S199000, C546S276700, C548S217000, C548S305100
Reexamination Certificate
active
07928105
ABSTRACT:
Disclosed are compounds of the following formula:in which R1, R2, R5, R6, R7, R31, u, and X are defined in the specification. Also disclosed are pharmaceutical compositions, kits, and articles of manufacture, which contain the compounds, methods and intermediates useful for making the compounds, and methods of using the compounds to treat diseases, disorders, and conditions related to PARP activity.
REFERENCES:
patent: 4138564 (1979-02-01), Freed et al.
patent: 4446323 (1984-05-01), Freed et al.
patent: 5055465 (1991-10-01), Davey
patent: 5166344 (1992-11-01), Davey et al.
patent: 5306819 (1994-04-01), Albaugh et al.
patent: 5405847 (1995-04-01), Dieter et al.
patent: 5424311 (1995-06-01), Billhardt-Troughton et al.
patent: 6121278 (2000-09-01), Jackson et al.
patent: 6197785 (2001-03-01), Jackson
patent: 6887996 (2005-05-01), Ferraris et al.
patent: 7235557 (2007-06-01), Ferraris
patent: 2006/0003987 (2006-01-01), Ferraris et al.
patent: 2006/0142294 (2006-06-01), Neamati
patent: 2006/0235034 (2006-10-01), Neamati et al.
patent: 2008/0161280 (2008-07-01), Gandhi et al.
patent: 2008/0269234 (2008-10-01), Gandhi et al.
patent: 2009/0093489 (2009-04-01), Neamati et al.
patent: 2009/0163545 (2009-06-01), Goldfarb et al.
patent: 2010/0048556 (2010-02-01), Okada et al.
patent: 2010/0113484 (2010-05-01), Gotanda et al.
patent: 2010/0120781 (2010-05-01), Neamati
patent: 0400583 (1990-12-01), None
patent: 2103613 (2009-09-01), None
patent: 2123301 (2009-11-01), None
patent: WO/94/05665 (1994-03-01), None
patent: WO/99/11649 (1999-03-01), None
patent: WO/2005/058843 (2005-06-01), None
patent: WO/2006/009734 (2006-01-01), None
patent: WO/2006/091246 (2006-08-01), None
patent: WO/2006/125179 (2006-11-01), None
patent: WO/2007/130468 (2007-11-01), None
patent: WO/2008/017883 (2008-02-01), None
patent: WO/2010/096426 (2010-08-01), None
Zaremba, Tomasz et al. “PARP Inhibitors development for systemic Cancer Targeting” Anti-Cancer Agents in Med. Chem., 2007, vol. 7, p. 515-523.
Savelli, Francesco et al. “Heterotricyclic systems. Part I. Synthesis of new dipyridopyrazines [I]” J. Heterocyclic Chem., 1992, vol. 29, p. 529.
Prunier, Herve et al. “Novel and selective partial agonists of 5-HT3 receptors. 2. Synthesis and biological evaluation of piperazinopyridopyrrolopyrazines, piperazinopyrroloquinoxalines, and piperazinopyridopyrroloquinoxalines” J. of Med. Chem., 1997, vol. 40, p. 1808-19.
Gangloff Anthony R.
Jennings Andrew John
Jones Benjamin
Kiryanov Andre A.
Brustein Mitchell R.
Russo Matthew J.
Takeda Pharmaceutical Company Limited
Willis Douglas M
Wilson James O
LandOfFree
Substituted... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2660829